This NDC is on FDA's drug shortage list (posted Jul 26, 2023)
Reported reason: Discontinuation of the manufacture of the drug
Product Information
METHYLPHENIDATE ER 36 MG TAB is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.7332 per EA under NDC 57664060888. Its NADAC has been published 257 times since Jan 20, 2021.
FDA first approved this application on Aug 19, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
36 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
57664060888
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
12/17/2025
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205135FDA Approved
8/19/2020
TE Code
AB
On Market Since
8/20/2020
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER 36 MG TAB has been published 257 times since Jan 20, 2021, and over the history we have for it it has declined 41.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7332 per EA |
|---|---|
| All-time high | $1.5527 (Jun 16, 2021) |
| All-time low | $0.6033 (Apr 17, 2024) |
| 52-week high | $0.7607 |
| 52-week low | $0.7332 |
| Median price | $0.8908 |
| Average price | $0.9336 |
| Largest weekly change | -34.7% (Apr 17, 2024) |
| Weeks tracked | 257 |
| Tracking since | Jan 20, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-3.6%
3Y
-29.5%
5Y
-44.3%
All
-41.7%
Last surveyed Dec 17, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER 36 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 36 MG TAB, manufactured by Sun Pharmaceutical Industries Inc., is $0.7332 per EA (NDC 57664060888), effective Dec 17, 2025.
How has the price of METHYLPHENIDATE ER 36 MG TAB changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER 36 MG TAB has declined 41.7%. It has been tracked across 257 weekly CMS publications since Jan 20, 2021.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 36 MG TAB?
Since Jan 20, 2021, the NADAC for METHYLPHENIDATE ER 36 MG TAB has ranged from a low of $0.6033 (Apr 17, 2024) to a high of $1.5527 (Jun 16, 2021), with a median of $0.8908 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER 36 MG TAB?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE ER 36 MG TAB, is $0.6665 per EA — about 9% below METHYLPHENIDATE ER 36 MG TAB.
Who manufactures METHYLPHENIDATE ER 36 MG TAB?
METHYLPHENIDATE ER 36 MG TAB (NDC 57664060888) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.
Is METHYLPHENIDATE ER 36 MG TAB in shortage?
Yes — NDC 57664060888 is currently listed in FDA's drug shortage database (posted Jul 26, 2023). Reported reason: Discontinuation of the manufacture of the drug.